Johnson & Johnson (JNJ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Johnson & Johnson | JNJ | Healthcare | Drug Manufacturers - General | 89 | 9.7% |
| Current Price (12/01) | $158.08 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 91,446.0 | |||
| Sales Growth Forecast | 4.8% | |||
| Net Profit Margin | 29.3% | |||
| Projected Shares Outstanding | 2,571.43 | |||
| EPS - Five year Forecast | $13.18 | |||
| Average P/E Ratio | 17.0 | |||
| Projected Average Price | $223.99 | |||
| Price Appreciation (Annualized) | 7.2% | |||
| Annual Dividend Yield | 2.5% | |||
| Projected Annual Return | 9.7% | |||
| Quality | ||||
| Financial Strength | 99 | 24.9 | ||
| EPS Stability | 93 | 23.2 | ||
| Industry Sales Growth Rate | 8.0% | 7.5 | ||
| Industry Net Profit Margin | 22.5% | 16.3 | ||
| Calculated Quality Rating | 71.8 | |||
| Fool CAPS | ||||
Total Players
13600
Outperforms
513
Underperforms
All-Stars (2372)
2315
Outperforms (98%)
57
Underperforms
|
||||
| Fundamental Data Updated: 11/12/2021 | ||||